NCT05656066

Brief Summary

This study aimed to evaluate two methods (pressure and vibration intervention) used to reduce pain during IM injections in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 19, 2022

Completed
Last Updated

December 19, 2022

Status Verified

December 1, 2022

Enrollment Period

1 month

First QC Date

December 9, 2022

Last Update Submit

December 9, 2022

Conditions

Keywords

anxietyfearpain

Outcome Measures

Primary Outcomes (3)

  • Children's Fear Scale (CFS)

    The Children's Fear Scale (CFS) is a scale used to assess the level of anxiety in children. The scale is a visual measurement tool with scores ranging from 0-4 points. It consists of five facial expressions, ranging from a neutral to a frightened expression, and is suitable for use with children aged 5-10 years (Inan \& Inal, 2019; McMurtry, Noel, Chambers, \& McGrath, 2011; Özalp Gerçeker, Ayar, Özdemir, \& Bektaş, 2018). The evaluation of the Turkish psychometric properties of the scale, which was developed by McMurty et al. for paediatric patients, was conducted by Özalp Gerçeker et al. (2018), and the scale was translated into the Turkish language (Özalp Gerçeker et al., 2018). The CFS has demonstrated good evidence of test-retest (r = 0.76, p \< 0.001), and inter-rater (0.51, P \< 0.001) reliability, as well as construct validity, (rs ¼ when used with children (McMurtry vd., 2011

    during procedure

  • The Children's Anxiety Meter-State (CAM-S)

    The Children's Anxiety Meter-State (CAM-S) assesses children's anxiety at medical procedures. It is drawn like a thermometer with a bulb at the bottom. It includes horizontal lines going up to the top (0-10). Children are asked to mark their feelings "right now" to measure state anxiety (Kleiber \& Mccarthy, 2006). CAM-S was validated in children aged 4-10 years during an intravenous procedure. It is significantly associated with all parent measures and observed distress ratings (Ersig et al., 2013). Gerçeker et al. (2018) conducted the psychometric properties of CAM-S in the Turkish population. They revealed a significant negative correlation between the CAM-S scores and children's ages (β = 0.340, p \< .001).

    during procedure

  • Wong-Baker FACES Rating Scale

    It is a horizontal scale developed by Wong and Baker in 1983 for children over 3 years of age who can express themselves. In this scale, pain scores are given to faces according to numerical values. The lowest score is "0" and the highest score is "10". As the score obtained from the scale increases, the severity of pain increases. During the application of the scale, it is stated to the child that each of the facial expressions belongs to a person. It is stated that the child who has no pain expresses a happy face, while the child who has a little or a lot of pain during the procedure has sad faces.

    during procedure

Study Arms (3)

The Vibration Intervention Group (VI)

EXPERIMENTAL

After the injection area was determined in the VI group, the vibration device was held for 30 seconds in the area to be injected, then the injection was applied by pulling up 3 cm while the device was operating.

Behavioral: The Vibration Intervention

The Pressure Intervention Group

EXPERIMENTAL

After the injection area was determined in the PI group, 30 seconds light pressure was applied with the thumb and then the injection was given

Behavioral: The Pressure Intervention

The Control Group

NO INTERVENTION

The routine IM injection was applied to the children in the control group.

Interventions

The vibration frequency of the massager, which accelerates blood circulation, is 6000 / min, it works with a 1.5 volt battery. Can be used easily with one hand. The vibration simulator design is based on the gate-control theory, which allows for a reduction in the perceived amount of pain experienced during injection by closing the pain gate in the spinal cord in creating a stimulus on the skin.

The Vibration Intervention Group (VI)

Pressure was placed in the ıntramuscular area properly 30 seconds before injection. Then the injection process was completed.

The Pressure Intervention Group

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • had no diagnosed physical or mental disability or chronic illness;
  • had no communication problems;
  • received single injection,
  • required seftriakson group of antibiotics for standardization; and received vastus lateralis muscle injection during the study.

You may not qualify if:

  • Parents who were unable to collaborate in the fear and pain evaluation,
  • overweight or underweight children (under the third or above the 97th percentile),
  • children with any incision or scar tissue in the injection area,
  • children who received a sedative, analgesic, or narcotic drugs (based on expert opinion) six hours before the procedure on the basis of parental statements and medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatice Uzşen

Samsun, Atakum, 55100, Turkey (Türkiye)

Location

Related Publications (2)

  • Drago LA, Singh SB, Douglass-Bright A, Yiadom MY, Baumann BM. Efficacy of ShotBlocker in reducing pediatric pain associated with intramuscular injections. Am J Emerg Med. 2009 Jun;27(5):536-43. doi: 10.1016/j.ajem.2008.04.011.

    PMID: 19497458BACKGROUND
  • Bilge S, Aydin A, Gun C, Aldinc H, Acar YA, Yaylaci S, Cinar O, Balci V. Comparison of the efficacy of ShotBlocker and cold spray in reducing intramuscular injection-related pain in adults. A prospective, randomized, controlled trial. Saudi Med J. 2019 Oct;40(10):996-1002. doi: 10.15537/smj.2019.10.24322.

    PMID: 31588477BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not know which group in. Researcher and nurse will know.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized, controlled, and experimental design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 9, 2022

First Posted

December 19, 2022

Study Start

August 1, 2022

Primary Completion

September 1, 2022

Study Completion

October 1, 2022

Last Updated

December 19, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations